Ads
related to: hormone deprivation for prostate cancer- Dosing & Administration
Once-A-Day Treatment For
Advanced Prostate Cancer
- View Dosing FAQs
HCPs: Learn About A
Once-Daily Treatment Option
- Dosing Card
Download The Dosing Card
& More Rx Info Here
- Dosing Information
Find Dosing Info For An
APC Treatment Option
- Dosing & Administration
Search results
Results From The WOW.Com Content Network
Androgen deprivation therapy (ADT), also called androgen ablation therapy or androgen suppression therapy, is an antihormone therapy whose main use is in treating prostate cancer. Prostate cancer cells usually require androgen hormones, such as testosterone, to grow. ADT reduces the levels of androgen hormones, with drugs or surgery, to prevent ...
In men with metastatic, hormone-sensitive prostate cancer, doctors may recommend adding taxane-based chemotherapy to hormone therapy. [45] This combination likely improves overall and cancer-specific survival by slowing the spread of the cancer. However, taxane-based chemotherapy may cause an increase in side effects. [45]
Paul L. Nguyen is an American radiation oncologist and researcher specializing in prostate cancer research and clinical care. Nguyen has worked with the Dana–Farber Cancer Institute, the Brigham and Women's Hospital, and Harvard Medical School, and his research has sought to assess the effectivity of hormone-targeted therapy in treating prostate cancer, the importance of social systems like ...
This a done by castration (sometimes chemical castration) or by prescribing female sex hormones and drugs called antiandrogens. It is employed in androgen deprivation therapy for prostate cancer, feminizing hormone therapy for transgender women and against other androgen-dependent conditions.
In accordance, therapeutic modalities that reduce androgen signaling in the prostate gland, referred to collectively as androgen deprivation therapy, are able to significantly slow the course of prostate cancer and extend life in men with the disease. [16]
Testosterone levels in the long-term androgen deprivation therapy of men with prostate cancer by different GnRH agonists administered at 3 month intervals (goserelin, triptorelin and leuprorelin). Dotted line is the threshold for the castrate range. [2]
Ads
related to: hormone deprivation for prostate cancer- 262 Neil Avenue # 430, Columbus, Ohio · Directions · (614) 221-7464
